Author details

Full Name

Roxana Mehran

Affiliation

ORCID

Career Start Year

1995

Papers

1425

H Index

143

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37696359	Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.		2024
37871781	Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE).		2024
36660810	Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes.		2023
36104217	Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes.	Heart	2023
36102667	Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials.	European Heart Journal - Cardiovascular Pharmacotherapy	2023
35583108	Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.	EuroIntervention	2023
36270496	The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.	International Journal of Cardiology	2023
35788828	Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.	Cardiovascular Research	2023
36411964	Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Associ	EuroIntervention	2023
37852695	The Heart-Brain Connection in MyocardialÂ Infarction in Women: A Dilemma to Tackle.		2023
37941790	Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review.		2023
37673491	Significance of Kidney Disease in Cardiovascular Disease Patients.		2023
37746717	Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.		2023
37923124	Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.		2023
37742213	Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.		2023
37741105	Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation.		2023
37659651	Nonadherence to dual antiplatelet therapy: old problems without new solutions.		2023
37587595	Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.		2023
37587580	Bleeding and Ischemic Risks of TicagrelorÂ Monotherapy After CoronaryÂ Interventions.	J Am Coll Cardiol	2023
37734299	Gender-Based Differences in Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions (Insights from a Large Single-Center Registry).		2023
37730292	Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.	J Am Coll Cardiol	2023
37995152	Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.	J Am Coll Cardiol	2023
37806185	Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.	Am J Cardiol	2023
37804290	1- or 3-Month DAPT in Patients With HBRÂ With or Without Oral Anticoagulant Therapy After PCI.	JACC Cardiovasc Interv	2023
37725677	Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial.		2023
38092517	North American Perspective on the 2023 ESC Guidelines for the Management of ACS.		2023
37639760	Prevalence and Outcomes of Patients With Acute Ischemic Stroke and Concomitant Non-ST-Elevation Myocardial Infarction (Results from the National Inpatient Sample 2016 to 2019).	Am J Cardiol	2023
37879803	Dyspnea-Related Ticagrelor Discontinuation After PercutaneousÂ Coronary Intervention.	JACC Cardiovasc Interv	2023
37632766	2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.		2023
37632756	2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.		2023
37870970	Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.		2023
37960983	Impact of Ethnicity on Antiplatelet Treatment Regimens for Bleeding Reduction in Acute Coronary Syndromes: A Systematic Review and Pre-specified Subgroup Meta-analysis.		2023
37866281	Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.		2023
37550123	Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.		2023
37609931	Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI.		2023
37609850	Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.	Circ Cardiovasc Interv	2023
37345664	Migraine and cardiovascular disease: what cardiologists should know.		2023
37094668	Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.		2023
36841245	Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis.		2023
37409644	Women in cardiovascular imaging: a call for action to address ongoing challenges.		2023
37407118	P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of CoronaryÂ Events.	J Am Coll Cardiol	2023
36649694	Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial.	Eur Heart J Cardiovasc Pharmacother	2023
36585350	Prevalence and Professional Impact ofÂ Mental Health Conditions AmongÂ Cardiologists.	J Am Coll Cardiol	2023
36583436	Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.	J Am Heart Assoc	2023
37465632	Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry).		2023
37398874	Artificial Intelligence - Advisory or Adversary?		2023
37335828	Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.	Circulation	2023
37081774	Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome.		2023
37080466	Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.	Int J Cardiol	2023
37459570	Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study.	Eur Heart J Acute Cardiovasc Care	2023